Genomate Health

The right drug. The first time. Every time.™
Pioneering Digital Drug Assignment for Precision Oncology.

#medicalAI #GenomateHealth #Genomate

[Genomate Health @GenomateHealth]

Many cancer patients are wondering whether all treatment options have been considered.

Genomate® Second Opinion combines physician oversight with AI technology to systematically evaluate genomic findings, treatment opportunities, and clinical evidence: https://t.co/ACT7WK2MAb

[Genomate Health @GenomateHealth]

Our platform analyzes complex tumor profiles and highlights evidence-based treatments, so clinicians can make confident, strategic moves.
Beating cancer takes more than new therapies. It takes clarity, foresight, and the ability to plan three steps ahead.

#ComputationalReasoning

[Genomate Health @GenomateHealth]

This #WorldCancerDay, we’re reminded that cancer adapts. It learns. It finds workarounds.

That’s why we need smarter tools, not just to keep up, but to think ahead. At Genomate Health, we use computational reasoning to help oncologists see the full board.

[Genomate Health @GenomateHealth]

Join our team at the @CI4CC 23rd Cancer Center Summit - booth #6!
Meet our CEO, Nabil Hafez, MS, MBA, and Founder & CSO, @IstvanPetak MD, PhD, who are eager to share how our #precisiononcology solutions are transforming patient outcomes and cutting treatment costs.

#CancerCare

[SelectUSA @SelectUSA]

Day Two of the 2025 #SelectUSASummit in a nutshell:

🎙️ Plenaries with US Governors & CEOs on emerging tech & FDI

⚡ Pitching sessions feat. global tech startups

🎉 US investment news from CBC Global Ammunition, @GenomateHealth, @TakeAquaAction, and @Citi

See you on Day Three!

[SelectUSA @SelectUSA]

📢 INVESTMENT NEWS: Precision oncology company @GenomateHealth has announced its formal entry into the U.S. market with an additional $2 million in funding!

Genomate’s expansion will make long-term contributions to the U.S. health care industry.

More: https://t.co/DHF3TH44Re

[Genomate Health @GenomateHealth]

We are thrilled to announce our formal entry into the U.S. market at the @SelectUSA Investment Summit!
Backed by $2M, we are committed to transforming oncology with our clinically validated platform, Genomate®, and establishing strong partnerships:
https://t.co/kS1mpv3Vx9

[Genomate Health @GenomateHealth]

We’re beyond excited to welcome Nabil Hafez, MS, MBA, as our CEO!

Founder @IstvanPetak, MD, PhD, will continue as Chief Scientific Officer. Full announcement here: https://t.co/RJIeqK7U3n

[Genomate Health @GenomateHealth]

Every cancer is unique. Your patient’s treatment should be too.

Don’t settle for one-size-fits-all care.

Order a Genomate Report today and bring the power of personalized medicine to your patient’s journey: https://t.co/4ofuxbacka

[Brecise @Brecise_eu]

A big thank you to everyone who contributed to the #BRECISE Kick-Off Meeting in Madrid! 🙌 Your expertise and dedication are paving the way for better cancer diagnostics & treatments. Now, full speed ahead on biomarker validation and clinical integration! 🚀 #EUProject

[Genomate Health @GenomateHealth]

With top academic institutions, hospitals, and industry leaders, we’re working to accelerate the validation of AI-powered biomarkers for prostate and bladder cancer. Our aim? To improve diagnostic precision, predict treatment responses, and ultimately enhance patient care.

[Genomate Health @GenomateHealth]

Exciting times at the @Brecise_eu Kick-Off Meeting in Madrid! 🎉 #GenomateHealth is proud to be part of this European initiative focused on transforming biomarker science into real-world clinical applications: https://t.co/nCJSN68fBQ

#CancerResearch #PrecisionMedicine

[Brecise @Brecise_eu]

🚀 The BRECISE Madrid Kick-Off Meeting has officially started!

Today, our partners have gathered for two days of discussions, collaboration, and strategic planning to advance biomarker-driven precision medicine. Exciting work ahead! 🔬💡

#PrecisionMedicine #Biomarkers #BRECISE

[Genomate Health @GenomateHealth]

Learn more: https://t.co/bNAJ5mM0mV

[Genomate Health @GenomateHealth]

We're finalists of the Digital Health Rewired Pitchfest 2025! 🚀
With Genomate®, we’re making it easier for clinicians to navigate the complexities of cancer diagnostics and treatment decisions—improving outcomes for patients and supporting healthcare systems like the NHS.

[Digital Health Rewired @DHRewired]

Congratulations to our #Rewired25 Pitchfest finalists in the Pre Revenue category! ⚡

Watch them pitch live at #Rewired25, where they’ll compete for the opportunity to work with CW+ to scale their innovative solutions.

More > https://t.co/z2Z78JsL29

[Genomate Health @GenomateHealth]

Happy to welcome our newest partners, Digosys/Thabis, as Vietnam exclusive distributor 👏 https://t.co/oL9ybxLM8G

[OncoDaily @oncodaily]

Join me in DC and NYC to discuss precision oncology and AI - @IstvanPetak
@GenomateHealth

https://t.co/EiC3JiTGk8

#Cancer #PrecisionOncology #AI #MedEd #MedNews #Health #Medicine #MedTwitter #OncoDaily #Oncology

[OncoDaily @oncodaily]

Advancing the fight against rare cancers - @GenomateHealth
https://t.co/cHgNkU2cQj

#BoneCancer #RareCancer #CancerPrevention #Cancer #OncoDaily #Oncology

[Genomate Health @GenomateHealth]

The Genomate Health team wishes everyone a healthy, joyful, and inspiring Independence Day! 🇺🇸